Sky Century Investment (SKYI) Net Income towards Common Stockholders Growth (1y) (2025 - 2026)

Sky Century Investment (SKYI) Net Income towards Common Stockholders Growth (1y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income Growth (1y) (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-304.98%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-5.04%
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-17.29%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	7.59%
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	-2,482.61%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	34.33%
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	390.91%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Sky Century Investment	393,547.71	393,283.71	26,045.00	66.68%

Download Data